In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Phase 1
Withdrawn
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Biological: AlloStim
- First Posted Date
- 2013-08-15
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Registration Number
- NCT01923233
- Locations
- 🇮🇱
Hadassah-Hebrew University Medical Center, Jerusalem, Israel
AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer
Phase 2
Withdrawn
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Biological: AlloStim®Procedure: cryoablationOther: Physician's Choice (PC)
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Registration Number
- NCT01741038
- Locations
- 🇹🇭
National Cancer Institute of Thailand, Bangkok, Thailand
Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers
Phase 1
Terminated
- Conditions
- Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
- Interventions
- Biological: AlloStim-8
- First Posted Date
- 2009-03-16
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT00861965
- Locations
- 🇺🇸
Immunovative Clinical Research, Inc, Carlsbad, California, United States
In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
Phase 1
Completed
- Conditions
- Metastatic Cancer
- First Posted Date
- 2009-03-13
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT00861107
- Locations
- 🇺🇸
Immunovative Clinical Research, Inc, Carlsbad, California, United States
A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
Phase 1
Completed
- Conditions
- LymphomaLeukemiaHematological MalignancyMultiple Myeloma
- Interventions
- Biological: AlloStim
- First Posted Date
- 2007-11-15
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT00558675
- Locations
- 🇮🇱
Hadassah-Hebrew University Medical Center, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath